{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:21Z","timestamp":1786654041794,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018606","name":"Natural Products Research Center of Guizhou Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bcp.2026.118196","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:29:36Z","timestamp":1782516576000},"page":"118196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia"],"prefix":"10.1016","volume":"252","author":[{"given":"Jian","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118196_b0005","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/s41375-024-02394-5","article-title":"HDAC7 is a potential therapeutic target in acute erythroid leukemia","volume":"38","author":"Zhang","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.118196_b0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ajh.26503","article-title":"Classification of myeloid neoplasms\/acute leukemia: global perspectives and the international consensus classification approach","volume":"97","author":"Arber","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcp.2026.118196_b0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41375-022-01735-6","article-title":"An MDM2 degrader for treatment of acute leukemias","volume":"37","author":"Marcellino","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2026.118196_b0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41408-024-01186-5","article-title":"What have we learned about TP53-mutated acute myeloid leukemia?","volume":"14","author":"Shahzad","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcp.2026.118196_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.62347\/GCUG1405","article-title":"Acute erythroid leukemia in a child: Insights from a rare case","volume":"15","author":"Gupta","year":"2025","journal-title":"Am. J. Blood Res."},{"key":"10.1016\/j.bcp.2026.118196_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1015081","article-title":"Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118196_b0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/cells11020248","article-title":"Spatial and temporal scaling of microtubules and mitotic spindles","volume":"11","author":"Lacroix","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118196_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41580-022-00473-y","article-title":"Mechanisms of microtubule organization in differentiated animal cells","volume":"23","author":"Akhmanova","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118196_b0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118196_b0050","article-title":"Tumor suppressor p53: biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Borrero","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118196_b0055","doi-asserted-by":"crossref","first-page":"11515","DOI":"10.2147\/CMAR.S269624","article-title":"Characteristics and management of TP53-mutated diffuse large B-cell lymphoma patients","volume":"12","author":"Qin","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2026.118196_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019249","article-title":"Predictive and prognostic impact of TP53 mutations and MDM2 promoter genotype in primary breast cancer patients treated with epirubicin or paclitaxel","volume":"6","author":"Chrisanthar","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118196_b0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trecan.2020.01.007","article-title":"TP53 mutations and outcomes in breast cancer: reading beyond the headlines","volume":"6","author":"Shahbandi","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bcp.2026.118196_b0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2478\/aiht-2019-70-3258","article-title":"An overview of microtubule targeting agents for cancer therapy","volume":"70","author":"Karahalil","year":"2019","journal-title":"Arh. Hig. Rada Toksikol."},{"key":"10.1016\/j.bcp.2026.118196_b0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","article-title":"Microtubule-targeting agents: strategies to hijack the cytoskeleton","volume":"28","author":"Steinmetz","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2026.118196_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105320","article-title":"Microtubule associated proteins as targets for anticancer drug development","volume":"116","author":"Khwaja","year":"2021","journal-title":"Bioorganic Chem."},{"key":"10.1016\/j.bcp.2026.118196_b0085","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood-2019-122540","article-title":"Anticancer activity of a highly potent small molecule tubulin polymerization inhibitor, AB8939","volume":"134","author":"Humbert","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118196_b0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12935-022-02624-9","article-title":"Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine","volume":"22","author":"Dhyani","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2026.118196_b0095","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming, drug resist","volume":"54","author":"Mosca","year":"2021","journal-title":"Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.bcp.2026.118196_b0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature14192","article-title":"Function and information content of DNA methylation","volume":"517","author":"Sch\u00fcbeler","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118196_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118196_b0110","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","article-title":"The epigenetic hallmarks of cancer","volume":"14","author":"Esteller","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118196_b0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbpa.2016.05.030","article-title":"Methyltransferase inhibitors for modulation of the epigenome and beyond","volume":"33","author":"Schapira","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118196_b0120","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118196_b0125","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00277-012-1537-8","article-title":"Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells","volume":"91","author":"Tsao","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcp.2026.118196_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/0008-5472.CAN-08-0245","article-title":"Inhibition of DNA methyltransferase activates tumor necrosis factor alpha-induced monocytic differentiation in acute myeloid leukemia cells","volume":"69","author":"Laurenzana","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118196_b0135","article-title":"Advances in epigenetic cancer therapeutics","volume":"12","author":"Hillyar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.bcp.2026.118196_b0140","first-page":"1324","article-title":"DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias","volume":"87","author":"Leone","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2026.118196_b0145","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/1878-0261.12744","article-title":"The DNA methylation landscape of hematological malignancies: an update","volume":"14","author":"Blecua","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118196_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/curroncol32020088","article-title":"The role of the DNA methyltransferase family and the therapeutic potential of DNMT inhibitors in tumor treatment","volume":"32","author":"Kim","year":"2025","journal-title":"Curr. Oncol. Tor. Ont"},{"key":"10.1016\/j.bcp.2026.118196_b0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40164-025-00678-9","article-title":"Advances and challenges in the treatment of myelodysplastic syndromes","volume":"14","author":"Thalla","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118196_b0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-025-01228-6","article-title":"Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block","volume":"15","author":"Ma","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcp.2026.118196_b0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41408-025-01290-0","article-title":"Validation of the 5th edition of the world health organization and international consensus classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort","volume":"15","author":"Shah","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcp.2026.118196_b0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12885-023-10742-4","article-title":"Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK\/ERK signaling","volume":"23","author":"Gao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2026.118196_b0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jep.2009.10.012","article-title":"Hepatoprotective and toxicological assessment of an ethnomedicinal plant euphorbia fusiformis buch.-ham.ex D.don","volume":"127","author":"Anusuya","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2026.118196_b0180","article-title":"Safety evaluation of a novel effervescent curcumin-ascorbic acid-polysaccharide-\u03b2-cyclodextrin inclusion complex: acute oral toxicity - fixed dose procedure (OECD TG 420) in mice","volume":"15","author":"Wanta","year":"2025","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.bcp.2026.118196_b0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tox.2012.10.013","article-title":"Toxicity of the synthetic polymeric 3-alkylpyridinium salt (APS3) is due to specific block of nicotinic acetylcholine receptors","volume":"303","author":"Grandi\u010d","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2026.118196_b0190","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","article-title":"Identification and mapping of a common proviral integration site fli-1 in erythroleukemia cells induced by friend murine leukemia virus","volume":"87","author":"Ben-David","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118196_b0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/ph17050628","article-title":"A carbon 21 steroidal glycoside with pregnane skeleton from cynanchum atratum bunge promotes megakaryocytic and erythroid differentiation in erythroleukemia HEL cells through regulating platelet-derived growth factor receptor beta and JAK2\/STAT3 pathway","volume":"17","author":"Yang","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2026.118196_b0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/md21050289","article-title":"Anti-leukemia activity of polysaccharide from sargassum fusiforme via the PI3K\/AKT\/BAD pathway in vivo and in vitro","volume":"21","author":"Du","year":"2023","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2026.118196_b0205","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3390\/cancers11111707","article-title":"Development of a MEL cell-derived allograft mouse model for cancer research","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118196_b0210","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood.2021011094","article-title":"Erythroid\/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia","volume":"141","author":"Kuusanm\u00e4ki","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118196_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002339","article-title":"Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar spindles","volume":"21","author":"Zhou","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2026.118196_b0220","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.3390\/molecules27175648","article-title":"Drugs that changed society: microtubule-targeting agents belonging to taxanoids, macrolides and non-ribosomal peptides","volume":"27","author":"Christensen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118196_b0225","first-page":"119","article-title":"Mitochondrial ROS accumulation inhibiting JAK2\/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer","volume":"39","author":"Cao","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bcp.2026.118196_b0230","first-page":"3125","article-title":"The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals","volume":"6","author":"Men","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bcp.2026.118196_b0235","article-title":"The cancer\/testis antigen gene VCX2 is rarely expressed in malignancies but can be epigenetically activated using DNA methyltransferase and histone deacetylase inhibitors","volume":"10","author":"Jakobsen","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2026.118196_b0240","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1128\/MCB.01360-05","article-title":"Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation","volume":"26","author":"Passeri","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118196_b0245","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.yexcr.2007.03.021","article-title":"Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement","volume":"313","author":"Hata","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2026.118196_b0250","doi-asserted-by":"crossref","DOI":"10.1177\/1177271919846454","article-title":"Oncogenic roles and inhibitors of DNMT1, DNMT3A, and DNMT3B in acute myeloid leukaemia","volume":"14","author":"Wong","year":"2019","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.bcp.2026.118196_b0255","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.2147\/DDDT.S265644","article-title":"Current perspectives on letermovir and maribavir for the management of cytomegalovirus infection in solid organ transplant recipients","volume":"18","author":"Razonable","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2026.118196_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151075","article-title":"Microtubule-targeting agents and their impact on cancer treatment","volume":"99","author":"\u010cerm\u00e1k","year":"2020","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118196_b0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2015.11.022","article-title":"Momordin ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K\/akt and MAPK signaling pathways","volume":"90","author":"Mi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118196_b0270","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/cts.13548","article-title":"DNA methyltransferase inhibitor exposure-response: challenges and opportunities","volume":"16","author":"Kagan","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bcp.2026.118196_b0275","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphar.2019.00385","article-title":"DNMT inhibitors increase methylation in the cancer genome","volume":"10","author":"Giri","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118196_b0280","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2010.08.001","article-title":"Targeting DNA methylation for epigenetic therapy","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:16:35Z","timestamp":1786652195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":56,"alternative-id":["S0006295226005356"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118196","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118196"}}